Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CAI:NIPH's Gross Margin % is ranked worse than 78.58% of 943
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs CAI:NIPH: 31.40
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile had a gross margin of 30.02% for the quarter that ended in Mar. 2026 => Competition eroding margins
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile had a gross margin of 30.02% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Gross Margin % Related Terms
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Gross Margin % Chart
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Annual Data
Trend
Jun24
Jun25
Gross Margin %
22.09
31.62
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Quarterly Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Gross Margin % vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH) has a Gross Margin % of 30.02% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile and its competitors. This is 12% above median its historical median of 26.86. Over the past decade, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Gross Margin % has ranged from 22.09 to 31.62. According to the industry distribution chart, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile ranks #741 out of 943 companies in the Drug Manufacturers industry, placing it in the top 78.6%.
Is El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Gross Margin % too high?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's current Gross Margin % of 30.02% is 12% above median its 10-year median of 26.86. Over the past 10 years, this metric has ranged from a low of 22.09 to a high of 31.62. The Drug Manufacturers industry median Gross Margin % is 48.54. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's value of 30.02% is 38.2% below this industry median. Based on the distribution chart, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile ranks #741 out of 943 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile has a GF Scoreâ„¢ of 28/100, reflecting its overall financial health beyond just this single metric.
How does El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile ranks #741 out of 943 companies for Gross Margin %. This places El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile in the lower half of its industry. The industry median Gross Margin % is 48.54. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's value of 30.02% is 38.2% below this benchmark. Historically, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's own Gross Margin % has ranged from 22.09 to 31.62 over the past decade. While the company's 10-year median is 26.86 vs. the industry median of 48.54, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 943 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's current Gross Margin % of 30.02% is 38.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's current Gross Margin % is 30.02%, which is 12% above median its own 10-year median of 26.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile stock overvalued right now?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH) has a current Gross Margin % of 30.02%. The current Gross Margin % is 30.02%, which is 12% above median its 10-year median of 26.86 and 38.2% below the Drug Manufacturers industry median of 48.54. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's overall GF Score™ is 28/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH), the current Gross Margin % is 30.02% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Business Description
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile manufactures and markets pharmaceuticals, medicinal materials, chemical products and surgical threads and medical solutions.
28GF Score
Get the complete analysis for CAI:NIPH
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI:NIPH has been successfully added to your 
